Penn engineers and collaborators have developed a transparent, micro-engineered device that houses a living, vascularized model of human lung cancer—a “tumor on a chip”—and show that the diabetes drug vildagliptin helps more CAR T cells break through the tumor’s defenses and attack it effectively.
(Image: Courtesy of Dan Huh)
Nov. 6, 13, 20, and 27, 9 a.m. to 12:30 p.m., $50